류마티스 관절염 공장, 좋은 품질을 사다 류마티스 관절염 상품 중국에서

N-메틸-N-((3R,4R) -4-메틸피페리딘-3-일) -7H-피롤로[2,3-d]피리미딘-4-아민 (477600-74-1)

This compound is mainly used for synthesis of Tofacitinib as intermediate B2. Product Name: N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine CAS No.: 477600-74-1 Assay: 98% End Use: Tofacitinib Molecular Formula: C13H19N5 Molecular Weight: 245.33 Shelf Life: 2 Years Package: 25kg/drum

토파시티니브 시트라트 (540737-29- 9)

Tofacitinib citrate is a Janus kinase inhibitor, trade name Xeljanz, for the treatment of methotrexate inadequate response or intolerance to severe active rheumatoid arthritis (RA) in adult patients. Product Name: Tofacitinib Citrate CAS No.: 540737-29-9 Assay: 99% Specification: CP, EP, In-house, as required Molecular Formula: C22H28N6O8 Molecular Weight: 504.50 Shelf Life: 2 Years Package: 25kg/drum

4-클로로-7H-피롤로[2,3-d]피리미딘 (3680-69-1)

4-Chloro-7H-pyrrolo[2,3-d]pyrimidine is an important intermediate in organic synthesis. In the synthesis of Tofacitinib, it is used as intermediate. Product Name: 4-Chloro-7H-pyrrolo[2,3-d]pyrimidine CAS No.: 3680-69-1 Assay: 98% End Use: Tofacitinib Molecular Formula: C6H4ClN3 Molecular Weight: 153.57 Shelf Life: 2 Years Package: 25kg/drum

(3R,4R) 1-벤질-N,4-디메틸피페리딘-3-아민 디히드로클로라이드 (1062580-52-2)

(3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride can be used as organic synthesis intermediates and pharmaceutical intermediates, for instance intermediate A for Tofacitinib. Product Name: (3R,4R)-1-benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride CAS No.: 1062580-52-2 Assay: 98% End Use: Tofacitinib Molecular Formula: C14H23ClN2 Molecular Weight: 254.8 Shelf Life: 2 Years Package: 25kg/drum

N-((3R,4R)-1-벤질-4-메틸피페리딘-3-일) -N-메틸-7-토실-7H-피롤로[2,3-d]피리미딘-4-아민 (923036-30-0)

This compound is mainly used for synthesis of Tofacitinib as intermediate. Product Name: N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine CAS No.: 923036-30-0 Assay: 98% End Use: Tofacitinib Molecular Formula: C27H31N5O2S Molecular Weight: 489.64 Shelf Life: 2 Years Package: 25kg/drum

에트라시모드 (1206123-37- 6)

Etrasimod is a novel oral, selective sphingosine 1-phosphate (S1P) receptor modulator for the treatment of adult patients with moderately to severely active ulcerative colitis. It can partially reversibly block the outflow of lymphocytes and reduce the number of lymphocytes in the peripheral blood, thereby reducing the migration of lymphocytes into the intestine and exerting a therapeutic effect. Product Name: Etrasimod CAS No.: 1206123-37-6 Assay: 99% Specification: CP, EP,

에틸2-(7-하이드록시-1,2,3,4-테트라히드로사이클로펜타[b]인돌-3-일) 아세테트 (1206124-13-1)

Ethyl2-(7-hydroxy-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetate is an intermediate of Etrasimod. Product Name: Ethyl2-(7-hydroxy-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetate CAS No.: 1206124-13-1 Assay: 98% End Use: Etrasimod Molecular Formula: C15H17NO3 Molecular Weight: 259.3 Shelf Life: 2 Years Package: 25kg/drum

4-클로로메틸-1-사이클로펜틸-2-트리플루로메틸벤젠 (957208-65-0)

4-ChloroMethyl-1-cyclopentyl-2-trifluoroMethyl-benzene is an intermediate of Etrasimod. Product Name: 4-ChloroMethyl-1-cyclopentyl-2-trifluoroMethyl-benzene CAS No.: 957208-65-0 Assay: 98% End Use: Etrasimod Molecular Formula: C13H14ClF3 Molecular Weight: 262.7 Shelf Life: 2 Years Package: 25kg/drum

1- ((1-에토시에틸) -4-(4,4,5,5-테트라메틸-1,3,2-디옥사보롤란-2-일) -1H-피라졸 (1029716-44-6)

1-(1-ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole is an intermediate for synthesis of Baricitinib, also for other compounds. Product Name: 1-(1-ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole CAS No.: 1029716-44-6 Assay: 98% End Use: Baricitinib Molecular Formula: C13H23BN2O3 Molecular Weight: 266.15 Shelf Life: 2 Years Package: 25kg/drum

2-(1-(에틸술포닐) 아제티딘-3-일리덴) 아세토니트릴 (1187595-85-2)

Baricitinib intermediate 2 is an intermediate for synthesis of Baricitinib. Product Name: 2-(1-(ethylsulfonyl)azetidin-3-ylidene)acetonitril CAS No.: 1187595-85-2 Assay: 98% End Use: Baricitinib Molecular Formula: C7H10N2O2S Molecular Weight: 186.23 Shelf Life: 2 Years Package: 25kg/drum

(1h-피라졸-4-일)-7-((2-(트리메틸실일) 에토시) 메틸)-7h-피롤로[2,3-d]피리미딘 (941685-27-4)

1-(1-ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole is an intermediate for synthesis of Baricitinib. Product Name: (1h-pyrazol-4-yl)-7-((2-(trimethylsilyl)ethoxy)methyl)-7h-pyrrolo[2,3-d]pyrimidine CAS No.: 941685-27-4 Assay: 98% End Use: Baricitinib Molecular Formula: C15H21N5O Molecular Weight: 315.45 Shelf Life: 2 Years Package: 25kg/drum

바리시티니브 인산화물 (1187595-84-1)

Baricitinib is a JAK1 and JAK2 inhibitor and have been used as a promising treatment for rheumatoid arthritis. Product Name: Baricitinib Phosphate CAS No.: 1187595-84-1 Assay: 98% Specification: CP, EP, In-house, as required Molecular Formula: C16H20N7O6PS Molecular Weight: 469.41 Shelf Life: 2 Years Package: 25kg/drum

N-(4-(2-아미노아세틸) -5-메토시-2-페노시페닐) 메탄수플라나마이드화수화물 149436-41-9

N-(5-Methoxy-2-Phenoxyphenyl) Methanesulfonamide is an intermediate of Ellamod. Product Name: N-(4-(2-Aminoacetyl)-5-Methoxy-2-Phenoxyphenyl) MethanesulfonamideHydrochloride CAS No.: 149436-41-9 Assay: 98% End Use: Ellamod Molecular Formula: C16H19ClN2O5S Molecular Weight: 386.85 Shelf Life: 2 Years Package: 25kg/drum; 1kg/bag; 100g/bag

N- ((5-메토시-2-페노시페닐) 메탄수프나마이드 123664-84-6

N-(5-Methoxy-2-Phenoxyphenyl) Methanesulfonamide is an intermediate of Ellamod. Product Name: N-(5-Methoxy-2-Phenoxyphenyl) Methanesulfonamide CAS No.: 123664-84-6 Assay: 98% End Use: Ellamod Molecular Formula: C14H15NO4S Molecular Weight: 293.34 Shelf Life: 2 Years Package: 25kg/drum; 1kg/bag; 100g/bag